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The object of this study was to assess the status of the cellular 
immune response in the year-old weak calf runt, as well as the 
therapeutic benefits of thymosin, a protein thymic extract shown 
capable of inducing the maturation of thymus-derived lymphocytes. 
Various assays currently available for evaluating the cellular 
component of the immune response, such as delayed hypersensitivity, 
lymphocyte proliferation, lymphokine production and humoral 
response to thymus-dependent antigens, were conducted. The 
results of these tests indicated no immunological abnormalities 
or deficiencies in weak calf responses when compared to the 
responses of normal calves, other than a minor depression in 
delayed hypersensitivity0 
The ability of thymosin to correct the deficiency in delayed 
hypersensitivity and to promote normal growth and development in 
the weak calf was examined, rfeak calves received 3̂ ,000 jug of 
thymosin a month for a period of four months and during this time 
their weights were monitored as well as their response to the 
tuberculin skin test antigen. After the four months, no 
discernible improvement in the weak calves receiving the thymus 
extract was observed that was not observed in the control animals, 
while the difference in delayed tuberculin hypersensitivity 
responses in thymosin treated animals were no longer significantly 
different from the responses of the normal animals, inconsistencies 
in the test results made it impossible to attribute this change 
to thymosin therapy. 
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Chapter 1 
INTRODUCTION 
The V/eak Calf Syndrome 
Investigations into severe calf losses in the Bitter-
root Valley of Montana in 1964 led to the recognition of a 
new disease condition of neonatal cattle (41). Because the 
calves afflicted with this disease appeared weak at birth 
and unable to rise, this condition became known as the 
V/eak Calf Syndrome (WC3). In recent years, WCS has become 
a prevalent problem in parts of the Western United States 
and Canada and has resulted in significant economic losses 
to ranchers due to late abortion and a high mortality of 
calves less than six weeks of age (52). Mortality rates 
have been reported to be as high as 80>5 in affected herds (10). 
Of depressing consequence of the disease condition is that 
a high number of calves surviving the afflection fail to 
exhibit normal growth and develop into runted animals. 
At or within the first few weeks after birth, weak-
syndrome calves exhibit a depression along with a reluctance 
to stand, move or even nurse. Polyarthritis, a crusting and 
reddening of the muzzle and lips and calf scours are also 
observed. These calves exhibit a marked leukopenia at birth 
averaging 1 x 10^ WBC/mm^ in comparison to 2.2 x 10^ VvBC/rnm^ 
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for normal calves (56). The leukopenia is transitory and 
shifts to a leukocytosis about four days later. Histopath-
ology of the weak calf is characterized by subcutaneous 
bilateral edema and hemorrhages of the extremities, hemor­
rhages on the third eyelid, tongue, esophagus and trachea, 
involution of the thymus, enlargement and edema of the lymph 
nodes, petechial hemorrhages of internal organs, polyarthritis 
and synovitis (10, 65). 
Early treatment of weak calves with intravenous injec­
tions of electrolyte solutions and transfusions of whole 
blood or the administration of immune sera proved beneficial 
for those calves less severely afflicted, but this did not 
alter the course of the runting syndrome associated with 
the disease. Later, thymosin, a protein thymic extract, 
was used in the treatment of weak calves (64). Again those 
calves less severely afflicted showed an improvement in 
health but no subsequent return to normal weight. 
A depression in cellular immune responsiveness has been 
observed in weak calves skin tested with tubercle bacilli. 
V/eak syndrome calves sensitized with Mycobacterium bovis, 
Paris strain bacille Calmette Guerin (BCG), failed to mount 
a delayed hypersensitivity response to the BOG skin test 
antigen (56). Other studies have shown that lymphocytes 
from newborn weak calves responded to a lesser degree than 
lymphocytes from newborn normal calves when stimulated with 
phytohemagglutinin (PHA), a non-specific I-lymphocyte 
mitogen (64). 
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Hunting Syndrome 
The induction of a runting syndrome is observed in 
laboratory animals after various experimental procedures. 
These procedures are carried out during the neonatal period 
and include thymectomy (35), administration of cortisone 
acetate (25) or sterile bacterial vaccines (13), the in­
jection of foreign immunologically competent cells (5) and 
infection with certain viruses (54, 57). The resulting 
syndrome is usually defined by the following characteristics: 
1) loss of body weight to less than 60;S, 2) clinical symp­
toms such as lethargy, periorbital edema, ruffled fur, 
lymphocytopenia, diarrhea and atrophy of the thymus and 
other lymphoid organs, 3) subsequent early death (54). 
Examination of organs of runted animals at autopsy 
shows many organs to be of subnormal size due to the deple­
tion in the number of normal parenchymal cells within the 
organs (39> 40). This organ abnormality can be differen­
tiated from those occurring during malnutrition which 
results in a decreased cytoplasmic volume and not in the 
number of parenchymal cells (33). In addition, a significant 
depletion of lymphocytes is observed in the lymphoid organs. 
The thymus of the runted animals lacks any histological 
resemblance to a normal thymus (57). The cortex is reduced 
to a thin perimeter of lymphocytes and the medula is re­
placed with histiocytes. This histological pattern is also 
observed in the enlarged lymph nodes of the runts. A 
leukocytosis due to an increase in the granulocyte population 
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is also present (57). The normal ratio of lymphocytes to 
granulocytes is completely reversed with 70-80/5 granulocytes 
observed in the differential count. 
The etiology of this runting syndrome has not been 
completely clarified and more than one mechanism may con­
tribute to the growth disorder of the various runts. Micro­
organisms appear to play some role in thymectoraized and 
Cortisone-induced runting in mice. On the other hand, 
axenic animals do not develop the runting syndrome after 
thymectomy and appear to have an increased resistance to 
runting induced by cortisone administration (43). Anti­
biotics reduce the severity of wasting that occurs following 
both types of treatment but not the runting caused by 
sterile bacterial vaccines (2). 
Immunologic mechanisms also appear to play a role in 
runting syndromes. Runting due to the injection of foreign 
immunologically competent cells is believed to result from 
the immunological response of the donor cells against the 
transplantation antigens of the host (54). 
Viral-induced minting may be due to the immunological 
destruction of lymphatic cells that acquire viral antigens 
as well as the direct cytopathic effect of the virus on 
lymphatic cells and its inhibitory effect on cell multi­
plication (54). Growth retardation has also been reported 
in human infants with congenital rubella (38) and cytomegalo­
virus infections (40). A subnormal number of parenchymal 
cells is also observed in many organs of these infants as 
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well as a decrease in lymphoid elements. Surviving infants 
are unable to mount any humoral response to these viruses 
until approximately one to two years of age. 
Cellular Immunity 
The immune response of an organism to a foreign antigen 
can manifest itself in two ways: the production of humoral 
antibody and/or the development of cellular immunity. 
Although the two responses are not entirely independent, 
the two mechanisms are distinctly different. 
The study of cellular immunity began with the investi­
gations of Landsteiner and Chase (33) in 1342. Their 
experiments showed that delaĵ ed hypersensitivity could be 
transferred to unsensitized hosts by lymphoid cells but not 
by serum from sensitized individuals. The delayed hyper­
sensitivity reaction is an immunologically specific response 
occurring in appropriately sensitized animals after re-
introduction of the antigen. The reaction occurs several 
hours after reinfection of the antigen and is characterized 
by increasing erythema and induration at the site of injec­
tion. The erythema and induration are the result of an 
infiltration of predominantly mononuclear lymphocytes and 
mononuclear phagocytes (33). 
It is now recognized that cell-mediated mechanisms are 
responsible for certain immune responses to a variety of 
antigens including viral, microbial, heterologous protein 
antigens, transplantation antigens (organ and skin grafts) 
5 
and autologous antigens (autoimmune disease)(33). 
Of the two classes of lymphocytes known today, thymus-
derived lymphocytes (T-lymphocytes) and bone marrow-derived 
lymphocytes (3-lymphocytes), it is the T-lymphocytes that 
are involved in these cell-mediated immune mechanisms 
(33, 45)# Enumeration of B-lymphocytes and T-lymphocytes 
can be accomplished based on their differing surface struc­
tures. B-lymphocytes have easily detectable membrane immuno­
globulins as well as receptors for complement and the Fc 
region of IgC, all of which serve as population markers (25). 
These markers are absent from T-lymphocytes, which are 
recognised by their formation of spontaneous rosettes with 
sheep erythrocytes (B-rosettes). The formation of E-rosettes 
is non-immunological but serves as a convenient marker of 
T-lymphocytes. These lymphocytes have been identified as 
thymus-derived lymphocytes by virtue of the inhibition of 
rosette forma/tion by anti-theta serum, anti-lymphocyte serum 
and asathioprine, but not by anti-immunoglobulin (3, 12). 
E-rosettes have also been reported to serve as a 
marker for bovine T-lymphocytes (13). The number of bovine 
peripheral blood lymphocytes (PBL) has been reported in the 
literature to range from 0/s (20) to 19',^ (18) with assay 
parameters varying from study to study. It appears that 
while all human and mouse T-lymphocytes form E-rosettes, 
only a subpopulation of bovine T-lymphocytes form E-rosettes (18) 
In vivo and in vitro assays based on the immune func­
tions of T-lymphocytes are currently being used to evaluate 
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cellular immunity. Delayed hypersensitivity skin testing 
is probably considered the most reliable in vivo procedure 
for the evaluation of cellular immune responsiveness. 
The development of a delayed hypersensitivity reaction at 
the site of injection of the skin test antigen indicates 
that the afferent, central and efferent portions of the 
immune response are functioning normally and that the 
ability to mount a non-specific inflammatory response is 
intact (51). 
The migration inhibition test, an in vitro assay shown 
to correlate with in vivo delayed hypersensitivity, is often 
used in human medicine. V/hen sensitised lymphocytes are 
stimulated in vitro by the sensitizing antigen, a soluble 
factor called migration inhibition factor (HIP) which 
retards the migration of macrophages and leukocytes from 
capillary tubes is produced. The production of MIF in 
response to the specific antigen gives an evaluation of 
lymphocyte function as it relates to cellular delayed 
hypersensitivity (44). 
In vitro lymphocyte proliferative responses (blasto-
genesis) are also used to evaluate cellular immunity. The 
induction of blast-like transformation of sensitized 
lymphocytes by the sensitising antigen can be quantified by 
measuring the incorporation of tritiated thymidine into 
newly synthesized DNA. Certain plant mitogens can also 
induce lymphocyte proliferation by reacting non-specifically 
with the cell surface and instigating the same series of 
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cellular events. Phytohemagglutinin (PHA) is one such plant 
mitogen, but unlike antigen stimulated proliferation where 
only a small fraction of the lymphocytes are sensitive, 
PHA induces blastogenic activity non-specifically in the 
majority of the ?—lymphocytes (45). 
Immunosuppression by Corticosteroids and Viruses 
Cellular immune responsiveness can be depressed non-
specifically by a variety of factors such as neoplastic and 
infectious diseases, trauma, X-irradiation, malnutrition 
and elevated corticosteroid levels (54). 
Corticosteroids are commonly used as chemotherapeutic 
agents for the suppression of undesirable immune and 
inflammatory responses. Although the precise mechanism 
of action is unknown, these steroids appear to act on many 
aspects of the immune response, from the inhibition of skin 
allograft rejection in mice to the inhibition of tuberculin 
skin test reactivity in man (7, 15). 
The effect of corticosteroids upon circulating lymphoid 
cells has been described by Fauci and Dale (14). A transient 
lymphopenia with decreases in circulating lymphocytes and 
monocytes is observed after a single intravenous dose of 
hydrocortisone. The depletion of lymphocytes is selective 
with a proportionately greater decrease in the number of 
'T-lymphocytes as measured by the E-rosette assay. This 
decrease in circulating lymphoid cells is believed to be 
due to redistribution to other body compartments from the 
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circulation rather than by direct destruction. 
A decrease in antigen responsiveness in vitro is observed 
after hydroxycortisone administration (14). This decrease 
correlates well with the suppression of delayed hypersen­
sitivity that occurs during corticosteroid therapy. Migration 
inhibition factor activity is also suppressed significantly 
by corticosteroids (4), which appear to disrupt inhibitory 
effect of MIF on the macrophage as opposed to antigen pro­
cessing by the macrophage or the ability of lymphocytes to 
produce MIF. 
Immunosuppressive effects of corticosteroids are of 
interest in studying immunosuppression in the weak calf due 
to the high levels of corticoids in newborn calves. Plasma 
corticoid levels in neonatal calves are extremely high, 
averaging 116.4 ng/ml at parturition and falling to a level 
of 2.2 ng/ml by day ten (22). Corticoid levels in calves 
with infectious calf diarrhea are generally higher than in 
healthy calves of the same age. Levels during the first 
four days of life are double that of healthy calves. Eight 
to 25/U of calves with infectious calf diarrhea die before 
the a,ge of two months, and many of those that survive are 
permanently sttinted (22). 
The ability of many viruses to suppress cellular 
immunity during and after infection has been demonstrated 
in various studies. In 1908 von Pirquet (63) reported 
suppression of tuberculin delayed hypersensitivity in 
children with measles, all of which had previously been 
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skin test positive. In 1919, Bloomfield and Mateer (63) 
reported the same suppression in patients with acute 
influenza infections. Many viruses known to suppress 
cellular immune responsiveness have since been added to 
the list. Mumps, rubella, Newcastle disease virus and 
poliovirus are among those shown to inhibit the in vitro 
response of normal lymphocytes to PHA while infants with 
congenital rubella infections also have a depressed lympho­
cyte response to PHA (26). This suppression of T-lymphocyte 
function may be the result of histological changes in thymic 
and other lymphoid tissue that has been observed in acute 
measles infections (63). 
Perhaps the most noteworthy observation in suppression 
of cell-mediated immunity induced by viruses are those changes 
effected by mouse thymic virus (MTV). Neonatal infection of 
mice with MTV, a herpesvirus, results in thymic necrosis and 
cellular depletion. Inoculation of newborn mice with MTV 
results in a syndrome resembling neonatal thymectomy and 
results in functional T-lymphocyte depletion (8). 
Thymic Immunodeficiencies 
Besides the non-specific immunosuppressing factors 
mentioned, immune responsiveness can also be suppressed by 
primary immunodeficiency diseases. Immunodeficiency diseases 
result from defects in the development of normal immune 
responses where either the ability to produce antibodies 
and/or the development of cell-mediated immunity is depressed 
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or absent. Over thirty discrete phenotypic patterns of 
immunodeficiency have been described in man (9)» Although 
classification of many of the clinical symptoms is difficult, 
distinct patterns have been recognized enabling the general 
classification of defects into three categories based on 
cellular response: 1) B-lymphocyte, 2) T-lymphocyte and stem 
cell deficiencies. Only T-lymphocyte deficiencies will be 
discussed in this thesis. 
The role of the thymus in the development of immunity 
was first suggested by the frequent occurrences of thymic 
abnormalities in children with immunological deficiency 
disorders. The thymus is a lymphoid organ comprised of 
lymphoid and epithelial cells. During embryogenesis, the 
thymus along with the parathyroid gland arises from the 
third and fourth pharyngeal pouch epithelium and in most 
species is fully developed by birth (23). The thymus exerts 
its influence on precursor bone marrow stem cells. These 
cells differentiate into immunocompetent T-lymphocytes in 
the thymus and are transported from the thymus to peripheral 
lymphoid tissues, blood and lymph (62). Failure of the 
thymus to develop properly results in thymic immunodeficiency, 
under which conditions precursor stem cells fail to dif­
ferentiate into T-lymphocytes responsible for cellular 
immunity. 
Congenital thymic aplasia in man, known as Di George's 
Syndrome, occurs when the thymus fails to arise during the 
sixth week of embryonic life. Cause for this embryonic flaw 
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is still unknown. Autopsy reveals little or no thymus and 
parathyroid tissues, and those infants surviving exhibit 
a high susceptibility to viral, fungal and bacterial in­
fections. In thymic aplasia, germinal center development 
and immunoglobulin synthesis remain normal, but the depletion 
of lymphocytes in the subcortical, thymus-dependent regions 
of the lymph nodes as well as the lymphoid sheaths of the 
spleen are prominent (46). Deficiencies in cellular immunity 
such as the loss of delayed hypersensitivity to common anti­
gens, loss of ability for skin graft rejection, lowered 
response of peripheral blood lymphocytes to mitogens have 
been observed. Transplants of fetal thymus tissue have 
been successful in correcting the deficit of T-lymphocytes 
and cellular immunity in Di George's Syndrome patients. 
Normal skin graft rejection, response to intradermal skin 
test antigens, in vitro response to mitogens as well as 
increased lymphocyte count and population of thymus-dependent 
areas are observed as early as 48 hours after the 
transplant (46). 
Congenital thymic dysplasia, or Nezelof Syndrome, is 
a genetically acquired thymic immunodeficiency in contrast 
to Di George's Syndrome which has no genetic involvement. 
In this autosomal recessive disease, the thymus is reduced 
in size, consists almost entirely of epithelial cells and 
lacks any Hassall's corpuscles. While the population of 
circulating ljnnphocytes is not depleted and immunoglobulin 
levels usually appear normal, cellular immune responsiveness 
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is impaired (9). In thymic dysplasia,, -transplantation of 
fetal thymus tissues does not correct the T-lymphocyte 
deficiency. An abnormality in the inductive function of 
the epithelial portion of the thymus is believed to be 
responsible for the immunologic deficiency (9). 
While the preceding are examples of blatant, primary 
thymic immunodeficiencies, persons with chronic mucocutaneous 
candidi as is s erve as examples of more subtle T-lymphocyte 
deficiency. In these cases the circulating population of 
T—lymphocytes is normal as well as their in vitro pro­
liferative responses to mitogens, but the expression of 
delayed hypersensitivity and lymphokine production is 
impaired (9). 
Effects of Thymectomy 
Thymectomy has been used as a laboratory procedure to 
induce artificially a thymic immunodeficient condition in 
laboratory animals. While the effects of thymectomy in adult 
animals are slight, thymectomy during the neonatal period 
produces a severe depletion of the T-lymphocyte population, 
defects in the development of immune functions and gross 
changes in the histology of lymphoid tissue (34, 46). 
The most notable result of thymectomy is the associated 
wasting disease characterised by decreased growth rate, list— 
lessness, ruffled fur, hunched posture, periorbital edema, 
diarrhea and death (23, 36). The cause of the wasting disease 
has been attributed to the animals1 increased susceptibility 
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to infectious diseases due to on inability to respond immuno­
logically to pathogenic organisms. Thymectomized animals 
given either antibiotics or kept in germ-free environments 
exhibit a reduction or no change in the incidence of wasting 
or none at all. 
Many of the immunological consequences of neonatal 
thymectomy are similar to those observed in congenital thymic 
aplasia. Thymectorn;,'- results in a reduction in the population 
of circulating lymphocytes (the immunologically competent 
cells responsible for cell mediated immunity) and depletion 
of thymus-dependent areas of the lymph nodes and spleen. 
Among the serious defects in cell-mediated immune responses 
observed are impairment of homograft rejection, inability 
to elicit delayed hypersensitivity reactions to tubercle 
bacilli and bovine serum o-lbumin and e, reduced humoral re­
sponse to certain antigens (i.e. sheep erythrocytes, human 
gajvima globulin and ova albumin) (36). 
Thymic Re c ons t i tution 
Thymic deficiencies have been treated by a variety of 
procedures. As mentioned earlier, reconstitution of patients 
with congenital thymic aplasia using grafts of fetal thymus 
tissue has resulted in restoration of immunological competence. 
Restoration of immunological competence in neonatally thy-
mectomized mice using lymphoid cell suspensions or thymic 
grafts have also been successful (36). 
I. lore interacting are the implantation studies using 
cell-tight Millipore diffusion chambers containing thymus 
tissue into peritoneal cavities of young thymectomized mice. 
These chambers permit large size molecular exchange (pore 
size approximately 0.1 jum in diameter) but restrict the 
passage of cells. Restoration of skin graft rejection and 
humoral antibody response to sheep erythrocytes and human 
gamma globulin have been observed in a majority of these 
animals. Circulating lymphocytes are only r:iodera,tely reduced 
in number, and the spleen and lymph nodes are almost normal 
in size and cellular content (31, 40). 
These studies suggest tha/fc thymic tissue produces a 
specific humoral factor that triggers differentiation and 
maturation of lymphoid precursor cells to immunologic com­
petence. Examinations of the tissue within the diffusion 
chambers several vreeks after their implantation shov/s only 
epithelial cells to be present. These findings suggest that 
the epithelial cells of the thymus are responsible for pro­
duction of the humoral substance (53) • 
r.Iore recently, interest has centered around the use of 
thymus cell-free extracts. A thymic factor called thymosin 
has been isolated from calf thymus tissue and has been shov/n 
to be involved in the development and maturation of lymphoid 
tissue by a variety of in vivo and in vitro studies (16,55). 
Thymosin treatment of neonatally thymectomized mice has been 
shorn to induce immunological competence. In these mice, 
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thymosin treatment has significantly reduced the incidence 
of wasting disease while increasing the number of circulating 
lymphocytes and conferring a partial restoration of cellular 
immunity as measured by homograft rejection (1). 
Thymosin treatment 1ms also been applied to human 
patients with thymic hypoplasia and has resulted in improved 
clinical appearance, the appearance of a previously depressed 
delayed hypersensitivity and an increased percentage of 
in vitro T-lymphocyte E-rosettes (60). 
Action of Thymic Hormones 
Restoration of lymphocyte activity to azothioprine, 
anti-lymphocyte serum and anti-theta serum in neonatally 
thymectomized mice by thymic hormones has been taken as an 
indication of its ability to induce immuiiocompetence in 
thymus-dependent lymphocytes (3, 16). This activity of 
thymic hormones on I-lymphocytes has been supported by the 
ability of thymic hormones to induce in vitro development 
of characteristic T-lymphocyte stirface antigens TL, Thy—1 
and Ly from populations of spleen and bone marrow cells of 
adult mice (27) • 'The presence of any one of these markers 
indicates that the cell has undergone thymus-directed 
differentiation. Cells from spleen and bone marrow of nu/nu 
mice can also bo induced to develop T-lymphocyte surface 
antigens. Since nu/nu mice are congenitally thymus deficient, 
the inducible cell must be a precursor coll that has not 
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undergone any thymus-directed process (26, 32). 
How thymic hormones induce immunocompetence is not fully 
understood. Experiments monitoring activation of membrane-
associated enzymes in lymphoid cells exposed to thymic 
hormones indicate that they exert their influence by activating 
membrane-associated adenyl cyclase which leads to a rise in 
intracellular cAKP (1). This elevation of membrane-associated 
enzyme activity is only observed in thymus-derived cells. 
It has been suggested that these hormones act on at 
least three distinct classes of lymphoid cells: pre—thymic 
stem cells, thymus-derived cells (Tq and T^ cells) and mature 
T—lymphocytes (Tg cells) (55). Thymic hormones appear to 
function by accelerating the development and maturation of 
stem cells into immunologically competent lymphocytes arid 
then function in their further differentiation into special­
ized T-lymphocytes such as memory, killer, suppressor or 
effector lymphocytes. 
Statement of Thesis 
weak Calf Syndrome has become a problem in the cattle 
industry resulting in significant economic loss to the cattle 
rancher. The possibility of thymic dysfunction in these 
animals is suggested by the absence of a, normal thymus, 
runted appearance and 'failure to respond normally to tuber­
culin skin test antigens. 
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Treatment with thymic extracts in other thymic deficient 
systems has been shown to induce immunological competence. 
Applicability of treatment with thymic extracts has been 
demonstrated in newborn weak calves as judged by significant 
improvement in health and increase in uptake of tritiated-
thymidine upon stimulation of lymphocytes with the T-lympho— 
cyte mitogen PIIA in an in vitro system (64). 
The purpose of this study was designed to: 1) evaluate 
the status of the immune system of the weak calf by measure­
ment of various immunologic parameters and 2) investigate 
the effects of treatment with thymosin, a protein thymic 
extract, on those parameters and on the general overall 
appearance of the weak calf. 
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Chapter 2 
MATERIALS AND METHODS 
Animalo 
Calves used in this study were made available through 
a loan obtained from Mr, Duane Van Meter, a cattle rancher 
in the Bitterroot Valley of Montana. All calves were approx­
imately one year of age at the start of this research, pro­
ject. These calves were classified as either normal or weak 
calves by Dr. Jack Ward, a practicing veterinarian in 
Hamilton, Montana, who first recognised the weak calf problem 
in 1964. The criteria used in the classification of the 
calves were: comparative sise for year-old calves, growth 
rate and hair coat texture (illustration 1). An attempt was 
made to utilise in this study calves believed to have been 
afflicted with varied degrees and intensities of the disease 
condition. 
Collection of Samples 
Blood samples v/ere collected from animals by Dr. Ward. 
Forty ml of venous blood was drawn by venipuncture from the 
jugular vein. Twenty ml was transferred to vacutainer 
collection tubes for the collection of serum and to tubes 
containing 1,000 units of preservative-free sodium heparin 
19 
Illustration 1. The comparative size difference of year-
old. normal and weak calves is illustrated in the following 
photograph. Other physical characteristics of the weak 
calf, such as rough coat texture and periorbital edema, 
can also be observed. 
20 
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(Lilly) for whole blood samplea. All samples were kept at 
ambient temperature during transport from Hamilton to the 
laboratory and were processed immediately upon arrival. 
Differential White Blood Cell Counts 
Blood smears were prepared from heparinized whole blood 
and stained with Wright's stain (Medi Chemicals Inc.) for 
differential V.BC counts (Table 1). After staining, the blood 
smears were examined under oil and a total of 200 cells were 
counted. Cell types were identified as lymphocytes, mono­
cytes, eosinophilic granulocytes, basiophilic granulocytes 
and segmented and juvenile neutrophilic granulocytes. 
Table 1 '.'.'right's staining procedure. 
1) Fix blood smear in absolute methanol for 1 second. 
2) Place slide in Wright's stain #1 (eosinate stain) 
for 20 seconds. 
3) Wash slide in distilled water. 
4) Place slide in Wright's stain i-2 (polychrome stain) 
for 20 seconds. 
5) Wash slide in distilled water and air dry. 
Total White Blood Cell Counts 
Using WBC diluting pipettes, heparinised whole blood was 
diluted 1:20 with Turk's diluting fluid (Table 2) for total 
leukocyte counts. Counting was done in Neubauer hemocyto-
meters. All four corner mm^ squares wore counted and the 
total leukocyte count was calculated using the following 
formula.: 
number of leukocytes counted x dilution x 10 
number of mnP squares counted 
*3 
leukocytes/mm 
Table 2 Turk's white blood cell diluting fluid. 
Glacial acetic acid ..... 2 ml 
Aqueous gentian violet 1 ml 
Distilled -atcr 100 ml 
Mix and filter sterilize. 
Ficoll-diatrizoate Separation of Peripheral Blood Leukocytes(PBL) 
Separation of PBL on ficoll-diatrizoate density gradients 
was conducted by the method of Boyum (6). Twenty ml of 
heparinized bovine blood was centrifuged in 40 ml conical 
centrifuge tubes at 650 x g for 30 min at 4°C. The buffy 
coat was removed and resuspended in Hank's BSS and carefully 
layered over 5 ml of ficoll-diatrisoate (Table 3) in a 15 ml 
conical centrifugc tube. The blood-ficoll gradient was spun 
at 400 x g for 20 min at 4°C. The cells at the ficoll and 
Hank's interface were harvested and washed in Hank*a BSS. 
The leukocyte pellet was resuspended and incubated in 0.830 
NH^Cl for 5 min to remove contaminating red blood cells. 
The leukocytes were washed two additional times in Hank's 
BSS and resuspended in tissue culture media. 
Table 3 Ficoll-diatrisoate 
1) Dissolve 9.63 g sodium diatrisoate (T.'inthrop Labs.) 
in 30 ml of distilled water and adjust the pH to 7*3. 
2) Add 72 ml of distilled water. 
3) Dissolve 6.35 g ficoll (Pharmacia) in the above solution. 
4) Heat sterilise at 121°C for 15 min. Store at 4°C in 
a foil covered bottle to prevent exposure to light. 
Blastogenesis 
Leukocytes separated via ficoll-diatrizoate were adjusted 
6 to a concentration of 1 x 10 cells/ml in 10 ml of RPMI media 
with 100 PCS (Table 4). Triplicate 1 ml samples were removed 
and placed in glass tissue culture tubes and labeled "control 
cultures." After discarding 2 ml, 0.05 ml of a stock PHA-P 
solution (Table 5) was added to the remaining 5 ml of the 
cell suspension to achieve a final PHA-P concentration of 
1 jil/ral. Triplicate 1 ml samples were removed and placed 
in glass tissue culture tubes and labeled "PHA-P cultures." 
All cultures were incubated at 37°C in 50 COg. 
After 72 hrs, the cultures were removed from the in­
cubator, and 0.1 ml of a stock tritiated thymidine solution 
(Table 6) was added to each tube to achieve a final concen­
tration of 1 juCi/ml. The cultures were returned to the 
incuba/fcor for an additional 24 hrs. 
After a total of 96 hrs of incubation, the cultures were 
processed for counting by liquid scintillation using a 
Nillipore sampling manifold. Using suction, cells 'were 
collected on damp Whatman GF/C filter paper and washed with 
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Table 4 RPMI 1640 media 
RPMI 1640 dry powder (Gibco) . . . . 
Triple distilled water . . 
Penicillin G 
1.0 liter 
100,000 units 
100,000 p.g Streptomycin sulfate 
Petal calf serum (l.Iicrobiology Associates) 
inactivated at 56 C for 30 min .... 100 ml 
Table 5 Phytoliemagglutinin-P (PHA-P) stock solution. 
RPMI 1640 media with 10^ PCS 9 ml 
Stock PHA-P solution was stored in 0.05 ml calibrated 
dropper bottles at - 70°C until used. Pinal concentration 
of tiie PHA-P stock solution is 5 JL.I1/IV2., 
Table 6 Tritiated thymidine stock solution. 
\ 
Thymidine, raethyl-JH. 1 mCi, specific activity 
71.5 Ci/mmole (ICIT) 1 ml 
RPKI 1640 media with 10'/$ PCS 99 ml 
Pinal concentration of the tritiated thymidine stock 
solution is 10 ̂ iCi/ml. Stock solution was stored at 
-70°C until, used. 
PHA-P (Difco) 1 ml 
4 ml of cold 3/j acetic acid. The cellular nucleic acids 
were precipitated with 6>o trichloroacetic acid and then 
washed with 3 ml of cold PBS pH 7.2. The filters were dried 
for 2 hrs in a 65°C oven and transferred to scintillation 
vials (Beckman) which were filled with 3 ml of POPjPOPOP 
scintillation flour (Table 7) and counted for 10 rain in a 
Nuclear Chicago Unilex III liquid scintillation counter. 
The counts of the triplicate samples were averaged to give 
one value for each leukocyte sample. The stimulatory index 
(S.I.) was calculated by dividing the counts of the PHA-P 
sample by the counts of the control sample. 
Table 7 Scintillation flour. 
POPOP (1,4-bis 2~(5 phenyloxazolyl) benzene (Sigma) 0.05 g 
POP (2,5-diphenyloxasole) (Sigma) 4,0 g 
Toluene • . . . . . • . . . • . • • . • • • . . • • 1  liter 
Store in brov/n bottle to prevent exposure to light. 
Irnmuno f luo r e sconce 
Two x 10^ leukocytes tha.t had been obtained vie, ficoll-
diatrizoate separation were placed in 12 x 75 mm test tubes 
and washed twice with PBS pIT 7.2. After the second wash, 
the cell pellets wore resuspended in 0.4 ml of a 1:30 
dilution of anti-bovinc globulin serum of rabbit origin 
•conjugated with PITC (Colorado Serum Co.). The cells were 
incubated, on ice at room temperature for 45 min and then 
washed four times in PBS with 3/$ PCS. The. leukocytes were 
resuspended in 0.25 ml of PBS with 50. '• glycerin and placed 
on glass slides under cover slips. All slides were viewed 
using an AKO fluorescence microscope. A total of 200 leuko­
cytes were counted and fluorescent cells were recorded as 
B-lyrnphocytes and non-fluorescent cells as T-lymphocytes. 
E—rosette Assay 
The E-rosette assay was carried out with modification 
by the method of Jondal et_ al (25). Leukocytes separated 
via ficoll-diatrisoate were resuspended ill Hank's BSS with 
7 / 10/i PCS at a coneentration of 1 x 10 cells/ml. One tenth ml 
of this suspension was added to 0.1 ml of a Vf> suspension of 
sheep red blood cells (SRBC). The cells were gently mixed 
and incubated at 37°C for 10 min. Following incubation, 
the cells were centrifuged at 200 x g for 5 min and allowed 
to sit overnight at 4°C. The following day the pelleted 
cells "/ere gently resuspended by rotating the conical cen­
trifuge tube on a horizontal axis until all cells were in 
suspension. The cells were added to o. cold Neubauer hemo-
cytometer and allowed to settle. Two hundred cells were 
counted and the number of rosette forming colls determined. 
A cell with three or more 3PJ3C adhering to its surfo.ee was 
considered to be a rosette. 
Humoral Response to a T-dependent Antigen 
To assay for production of antibody to a T-dependent 
antigen, all calves received 5.0 ml intravenous injections 
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of a 5.0 mg/ml preparation of human albumin fraction V 
(Sigma). Serum camples were collected on day 0, 7 and 14. 
Anti-human albumin antibody was measured by indirect 
hemagglut inat i on. 
Indirect hemagglutination: Using "U" bottom microtiter 
plates (OECO), each test -'/ell in columns 1-12 received 50 jaI 
of PBS pH 7.2 with 2',o normal rabbit sera (NKS) • Fifty p.1 of 
whole sera was added to well 1 and titrated out through well 
12 using 50 p.l microdiluters. Ml wells then received 50 jul 
of a 0.5';'' suspension of SRBC sensitised with human albumin. 
Controls of tanned and sensitised SRBC wore included in the 
experiment. The plates were incubated at room temperature 
for 2 hrs and the titers determined. 
Sensitization of SRBC's; A 3/» suspension of SRBC in PBS 
pH 7.2 was mixed with an equal volume of a freshly prepared 
1:40,000 dilution of tannic acid (Baker) and incubated in a 
37°C water bath for 15 min. After incubation, the SRBC were 
washed once in PBS and resuspended in a 3'/j suspension. The 
SRBC suspension was then mixed v/ith an equal volume of a 
5.0 mg/ml preparation of human albumin fraction V and in­
cubated at room temperature for 15 min. The SRBC were washed 
twice in PBS and resuspended at a concentration of 0.5/$ in 
PBS pll 7.2 with 2-1 NRS. 
Immunoele c trophoresis 
Immunoelectrophoresis was performed using 1^ agarose 
(Seakem) in veronal buffer (Table 8) oil a glass microscope 
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slide. Electrophoretic separation of bovine serum was 
carried out at 3 maraps/olide over a 3 hr period, /aiti-bovine 
sera (rabbit origin) was added to troughs cut into the agarose 
slides and the slides were incubated in a humid chamber at 
room temperature for 48 hrs. Evaluation of normal and weak 
calf sera was done by comparing the immunoelectrophoretic 
pattern (precipitin arc shapes, intensities, general appear­
ance and electrophoretic location) of the various sera after 
precipitation with anti-bovine sera. 
Table 3 Veronal buffer pH 8.4. 
0.2 I-.I sodium barbitol (Mallinckrodt Inc.) ..... 50 ml 
0.2 LI HC1 S ml 
Distilled water .141 ml 
Delayed Hypersensitivity to BCG 
The Paris strain of BCG vaccine (43) was obtained from 
stock maintained in the Stella, Duncan Institute, University 
of Montana., Missoula, Montana. The initial stock cultures 
were diluted in Dubos broth to achieve an optical density of 
K-100 on a Klett-Gunmcrson photoelectric colorimeter and 
stored as the working solution in vials at -70°C until ready 
to use. 
All calves were vaccinated with 2.5 jtiI of the BCG vaccine 
via intramuscular injections. Two weeks after vaccination, 
the calves were skin tested in the caudal fold with 800 p.g 
of BCG protoplasm. Skin tests were measured 72 hrs after 
being administered. 
The BCG protoplasm was obtained from the Stella. Duncan 
Institvite and was prepared by re suspending twice-washed BCG 
bacilli in distilled water at a concentration of 10-15 g 
(net v'eight) of bacilli per 100 ml. Cells were ruptured in 
a Sorval Ribi coll fractionator at 45,000 psi, and the 
effluent was centrifuged at 27,000 x g for 1 hr to remove 
cellular debris. The supernate, referred to as BCG proto­
plasm, was lypholyscd and stored at -20°C. 
Macro phage T:!i gr at ion Inhibition Assay 
Production of MIP: Leukocytes separated via ficoll— 
6 diatrisoate were adjusted to a concentration of 5 x 10 
leukocytes/ml in II-192 media with 10;.' PCS (Table 2). Two 
ml of the leukocyte suspension was placed in duplicate tissue 
culture tubes. One tube received 100 ;ug of the BCG skin test 
antigen and the control tube received none. The cultures 
were incubated at 37°C for 43 hrs in 57* COg. After incubation, 
the leukocytes were centrifuged at 400 x g for 10 min, and 
the supernate fluids containing the MIP were removed. The 
supernates were stored at -70°C until used. 
Collection of guinea pig macrophages: Normal guinea 
pigs received intraperitoneal injections of 30 ml of sterile 
mineral oil to increase the number of macrophages in the 
peritoneal cavity. Approximately 72 hrs later, the animals 
were sacrificed and tacked on an autopsy board. After the 
abdomen was gently kneaded, 50 ml of cold, sterile Hank*s BSS 
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with 10 units of preservative-free heparin (Lilly)/ml was 
injected into the peritoneal cavity. An incision was made 
into the peritoneal wall, and the fluid withdrawn with a 
50 ml syringe and placed in a cold separatory funnel. Upon 
standing, the layers soon separated and the aqueous layer 
was decanted into cold, siliconized, 40 ml centrifuge tubes 
and were centrifuged at 200 :c g for 10 min at 4°C. The cells 
were collected and washed twice v/ith Hank's BSS without 
heparin. After the final 'wash, the cells were resuspended 
to a final concentration of 10';•> by volume in 11—199 media, 
containing 1 5£,j guinea pig serum. 
HIP assay: Capillary tubes were filled to 3/4 volume 
with the macrophage suspension end one end plugged with warm 
paraffin wa". The capillary tubes were then placed in 
sterile tubes 'with cotton plugs on the bottom and centri­
fuged a.t 200 g for 5 min to pack the cells. The capillary 
tubes v,rere cut at the interface between the cells, and the 
supernate with, a diamond pencil, and the portion with the 
cells was attached to the bottom slide in sterile Kackness 
chambers with silicon grease. The Ilackness chambers were 
incubated at 37°C for 24 hrs. The results were recorded by 
drawing scale drawings of the migration patterns, and the 
percent inhibition was calculated using the following formula: 
inhibition -1.0- ML x 100 
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Table 5 K-199 media with Earl1 s co.lts 
II-199 powder (Gibco) .. 9«9 g 
Triple distilled water .......... 1 liter 
Penicillin G 100,000 units 
Streptomycin sulfate 100,000 )xq 
IIarIC03 (Baker) 1.5 £ 
Fetal calf serum (Microbiological Associates) 
inactivated at 56 C for 30 rain 100 ml 
Processing of Thymus Extract 
'Thymosin was extracted from bovine thymus glands by a 
modification of the method of Goldstein and YThite (17). 
Bovine thymus glands obtained from a local abattoir were 
homogenised in Y/aring blenders with 0.35^ NaCl. The homo-
genate was centrifuged in 250 ml plastic centrifuge bottles 
at 3,500 x g for 5 min at 4°C. The supernatant fluid was 
decanted into 500 ml glass flasks and placed in 80°C water 
baths for 15 min. Most of the precipitate wo.s removed by 
contrifugation o.t 3,500 x g and then cleared further by 
centrifugation at 16,000 rpm for 1 hr in a Sorval high speed 
centrifuge. The clear supernatant fluid was decanted and 
precipitated with acetone at 4°C. Acetone precipitation was 
accomplished by adding the clear supernate to 10 volumes of 
cold acetone with constant stirring. The precipitate formed 
was placed in on evaporating dish and allowed to sit overnight 
in the cold room. The dried precipitate wo.s resuspended in 
0.1 II phosphate buffer pH 7.2 by constant stirring for 3 hrs 
and then centrifuged at 3,500 x g for 15 mill. The oupcrncito 
was collcoted by clo canting end then precipitated with 
saturated (NIL,) at room temperature. The final pre-
lr c. Lr 
cipitate v.*as resuspended in distilled -water and dialysed 
overnight against tv:o changes of distilled water to remove 
the (HIL) oSO,. • The suspension was lypholysecl and stored L\ £. L\-
at —20°C. 
Adjqini s t rat ion of jlhymus Extracts 
Calves numbered 10-15 and 25-23 received 30,000 ug of 
thymosin monthly in two intramuscular injections over a 
period of four months. The first injection v;ao administered 
in 5.0 ml of PB3 at a concentration of 1,000 jig/ml• The 
second injection was administered in 5.0 nil of a 50;..; PIS0 -
50;.' peanut oil (Planters) mixture at a concentration of 
5,000 thymoo in/ml.. 
Statistical Analysis of .Data 
Statistical analysis of the data was done using the 
Mann- .'hitr.oy U The !J test is a nonparr.motric test 
tb.Clt i. ' i1 r'n 10 " "it 071*2 PJ10 " 'he ti'1 OP t' "0 i.'lO-O 031 do lit P̂OIIPO 
hooii :rovi !;hp -;o.rulrtion (30 ) • .he level of 
n:v-rn f i ornee -i .0 oh hh.pof 1 rj o< 1 cv.lr 'si-iv* the v.?luo of the 
rri;atiotic 'I in o'-e '* onnorijaent • 
:no *'1,; "if ̂  U 'joit, the dc/ba fron the t"'0 f:roupo .opc 
combined on-"1 rT1 "O'"7 in orfrr^ of deeper"p n,r* eioc • fhe lovoot 
ecorc ic roox^r"^ tp-o 1 or -cot po.nh* hie rjup of the p^nhec 
scores in each group is calculated and used in the following 
formula: 
U = n 2̂ + 1). - R1 or U = n^n2 + .n2,(n.| ,1l - R 
n^ - number of items in the smal3.er group 
n2 - number of items in the larger group 
R.j = sum of the ranks of the items in the smaller group 
R2 = sum of the ranks of the items in the larger group 
The smallest value of U is calculated and used to find 
the level of significance in the appropriate table (50). 
When the statistic is assigned a p value (probability value) 
less than 0.05, the tv.-o groups are considered to be signifi­
cantly different and axe considered to be tv/o separate 
populations. 
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Total and Differe 111ia], Leukocyte Values 
Comparisons of differential leukocyte values (Table 10) 
between normal and we ale calves showed 110 significant dif­
ference. AILvalues fell within the range of normal bovine 
values .as reported by Schism (47). The average lymphocyte 
differential of normal and weak calves were 74.1?^ and 74 • 2$ 
respectively. The average total leukocyte count was found 
to be higher in normal calves (7,833 Y/BC/mm^) than in weak 
calves (6,609 V/BC/mrr^), but this difference was not found 
to be significant (p> 0.05). 
Separation of Peripheral Biood Leukocytes 
Ficoll-diatrisoate density-gradient centrifugation was 
found to be an effective method for the isolation of a 
reasonably pure population of mononuclear lymphocytes and 
monocytes. The lymphocyte population was found to sediment 
at the interface between the ficoll-diatrizoate and the 
Hank's BSD while the granulocytes were distributed throughout 
the ficoll-diatrisoate, directly above the erythrocyte pellet. 
Granulocyte contamination was found to bo less than 5'p as 
determined by differential staining of the purified lymphocyte 
preparation and lymphocyte viability, measured by trypan blue 
Table 10 Total and differential leukocyte valuea of year-old normal and weak calves. 
Number 
-,'j lymphocytes ?-> monocytes 'J '/'eosinophils Total V/BC/mmJ segmented -juvenile x 
10 74.0 6.9 13.0 
11 71.5 5.0 14.0 
13 53.9 2.0 23.5 
14 64.5 1.0 22.5 
1 5 84.5 3.5 5.0 
17 61.0 2.5 24.5 
13 30.5 0.5 14.5 
20 84.0 2.0 11.0 
22 30.5 2.5 11.9 
o ̂ 71.5 1.5 13.5 
24 81.0 *5 R J . -x 11.0 
25 76.0 1.5 16.5 
27 82.5 4.5 9.0 
average 74.2 2.8 14.6 
avs 
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exclusion, was grea/fcer than 99% The ptirified lymphocyte 
preparation was used in all subse.qtient in vitro assays. 
Occasional difficulties arose in the separation of PBL when 
agglutination of buffy coat layers occurred. These samples 
were discarded and new blood samples obtained end processed 
whenever possible. 
."Determination of Lymphocyte Subpopulatioils 
Lymphocytes were divided into two major subpopulations 
based on immunofluorescence after incubation with PITC 
conjugated anti-bovine globulin serum (Colorado Serum Co.). 
No difference was observed between normal calves and weak 
calves in the percentage of B-lymphocytes (fluorescent cells) 
and T-lymphocytes (lion-fluore scent cells) within the total 
population of lymphocytes (Table 11). Y-.'eak calves were found 
to have 31.9/^ B-lymphocytes and 69.1^ T-lymphocytes whereas 
normal calves had 33.0^ B-lymphocytes and 67.0/3 T-lymphocytes. 
A further division of the population of T-lymphocytes 
was made using the E-rosette assay. This subpopulation of 
T-lymphocytes was also found to be consistent in both groups. 
The population of rosette forming colls (PJ?C) was 14.9/^ in 
normal calves and 15.2,in weak calves. 
B1as t ogeno s i s 
Lymphocyte stimulation bj/ PHA-P 'was observed in both 
normal calves and weak calves. The results of the blasto-
genesis study are shown in Table 1?. Although weak calves 
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Table 11 Lymphocyte subpopulations present in peripheral 
blood of normal and weak calves. 
Number Iv-rosettes B-lympho cyt e: 
Normal 
12 
16 
19 
21 
26 
28 
average 
calvej 
3.0 
5.5 
2.0  
7.0 
3.5 
5.5 
4..Q 
i  9 ^ . 
33.0 
36.5 
34.0 
26.5 
5 
33.0 
34, 
67.5 
67.0 
63.5 
66.0 
72.5 
65.5 
67.0 
Weak Calves 
10 12.5 28.0 72.0 
11 13.5 27.5 72.5 
13 13.0 35.0 65.0 
14 16.0 35.0 65.0 
15 18.0 30.5 69.5 
17 14.5 34.0 66.0 
18 10.0 29.5 70.5 
20 14.0 36.5 63.5 
22 16.5 32.0 68.0 
23 14.5 34.5 65.5 
24 16.0 28.0 72.0 
25 18.0 34.0 66.0 
27 13.0 30.0 70.0 
average 1^.2 31.9 68.1 
1 O JO 
Table 12 Bias "to genie response of normal and weak calf 
peripheral blood lymphocytes after stimulation 
" • -pi.T A 
•, _L L>ll J- iiii—1 • 
Number Control, cpm PHA-P cpin S.I." 
Normal calves 
12 1,711.9 37 324.4 22.1 
16 918.5 13 968.5 15.2 
19 1,074.8 78 652.9 73.2 
21 1,444.6 36 180. 4 25.0 
26 1,273.8 14 449.0 11.3 
28 2,134.5 89 012.2 41.7 
average 1.426.4 45 014.6 31.4 
Y/eak calves 
10 816.2 8 078.4 9.9 
11 1 ,870.5 11 609.0 6.2 
13 1 ,005.9 78 340.5 72.1 
14 1 ,924.5 84 006.7 44.1 
15 1 ,577.8 25 839.0 16.4 
17 739.8 55 741.0 75.3 
18 1 ,219.4 64 055.4 52.5 
20 1 ,352.9 81 988.0 60.6 
22 1 ,727.7 74 730.0 43.3 
23 1 ,398.7 54 062.6 38.7 
24 1 ,532.0 11 166.3 7.3 
25 1 ,756.4 68 502.0 39.0 
27 1 ,663.6 73 295.9 44.1 
average 1 ,435.8 53 248.1 39.2 
"^Stimulatory inde:c (S.I.) = PHA-P cpm/Control cpm. 
had an. overall higher rate of tritiated thymidine incorpor­
ation than normal calves as indicated by the higher average 
stimulatory index (S. !•), this wa.s not found to bo significant 
(p <0.05)• The average S.I. of normal calves was 31.4 with 
S.I. values ranging from 11.3 to 73.2. The average S.I. of 
weak calvos vas 35.2 ;"ith S.I. values ranging from 6.2 to 75.3. 
Humoral Rcponse to a T-dependent Antigen 
A humoral response to human albumin fraction V, a 
T-dependent antigen was observed in both weak calves end 
normal calves. Bay 14 antibody titers, measured by hemag­
glutination ranged from 1:16 to 1:28 in weak calves end from 
1:8 to 1:64 in normal calves. No difference in the ability 
of normal and weak calves to respond to human albumin fraction 
V v -as o b s e rv c d. 
Inmunoelectrophore sis 
Since the only bovine anti-sera available was anti-whole 
bovine sera (rabbit origin), comparative Immunoelectrophoresis 
was done rather than quantitative Immunoelectrophoresis. 
Evaluation of normal and woak calf sera was done by comparing 
the immunoelectrophoretic patterns of the various sera after 
precipitation by anti-whole bovine serum. 
The results of the imnLinoolectrophoresis study showed 
no discernible differences in the electrophoretic patterns 
of normal and weak calves (Illustration 2). No precipitin 
arcs observed in normal calf patterns were absent in the pat­
terns of weak calvos and no additional arcs wore present either. 
40 
Table 13 Humoral response to human albumin, a T~dependent 
o.ntigen, in normal and vreak calves. 
Number Day 0 Day 7 Day 14 
Normal calve".: 
12 <1:4 1 16 1:16 
1 6 1 :4 1 16 1:64 
19 1:4 1 16 1: 32 
21 < 1 :4 1 1:32 
26 <1:4 1 16 1 :3 
o O O 1:4 1 16 1 :16 
V/eal: calves 
10 1 : 4 1 : 32 1:32 
11 < 1 :4 1 • 3) O 1 . 70 1 • J> 
13 < 1 :4 1 • 1:16 
14 1 :4 1 : 1 6 1:16 
15 < 1 :4 1 : 32 1 :32 
17 1 :4 1 : 32 1:64 
13 1 • ,i • 'r 1 . r* o • J' 1 :32 
20 < 1 :4 1 : 32 1 :1 23 
i... el ^ 1 : 4 1 164 1 :64 
9 <1 :4 1 : 16 1:16 
24 <1 . A 1 : 16 1 : 32 
r> ;~~ 
c -: ) <1 : 4 1 : 32 1 :32 
27 <1 :4 1 : 32 1 i j 2 
Illustration 2. Sample irnmimoelcctrophorotic patterns 
normal calves (#21 and 28) and v/eak calves 17 and 22) 
21 
28 
17 
22 
Dolayed Hypcrs elis it ivity t o BCG 
All c0-1 vco immunised with the BCG vaccine were found to 
"be capable of mounting a delayed hypersensitivity response 
when injected with 0.2 ml of the BCG skin test antigen 
(BCG protoplasm). Skin tests were administered in the caudal 
fold two weeks after immimi:;;ation v;itli the BCG vaccine, and 
the area of induration was measured 72 hrs after the in­
jection was given. 'The results of the skin tests are given 
in Table 14. A positive delayed hypersensitivity response 
is normally considered to be indicated when the area of 
induration is 3 mm or greater at the test site 24 hrs after 
injection of the skin test antigen (51). 'The 72 lir time 
period was used in this study since the responses 'were 
greater than the 43 hr responses and this permitted better 
resolution "between the various responses. 
The data in Table 14 indicates that, whereas both normal 
and weak calves -•ere ce.pa.blc of mounting positive delayed 
tuberculin hypersensitivity responses, the area of induration 
was significantly greater in normal calves (p < 0.001). 
Thymosin The rapy 
Thymosin therapy in 10 of the 19 calves (3 normal and 
7 weak calves) consisted of monthly injections of 30,000 j.ig 
of thymosin. The remaining 9 calves (3 normal and 6 weak 
calves) served as controls and recoived no thymosin or 
placebo. During the course of thymosin therapy, no outward 
physical changes or improvements were noted in weak calves 
Table 14 Delayed tuberculin responses in normal and weak 
calves sensitised v/itli 3CG-. 
Number Delayed Hypersensitivity Response in cm, 
Normal calves 
12 
16 2.0 : o ^ 
19 2.0 x 2.0 
21  1 .5  -  2 .0  
26 2.0 x 2.0 
28 2.0 x 2.5 
.Veal: calves 
10 2.0 x 1.5 
11 0.75 :: 0.5 
13 1.0 x 1.0 
14 1.0 x ' 1.0 
15 0.75 x 1.0 
17 1.5 x 1.5 
13 1.25 x 1.25 
20 1.5 x 1.0 
22 1.5 x 1.5 
23 1.0 x 1.5 
24 1.5 x 2.0 
25 1.0 x 1.5 
27 2.0 x 2.0 
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treated with thymosin that were observed in the controls. 
General improvement in the outward appearance of the weak 
calves, such as hair coat texture and periorbital edema, 
were noticed in all calves during the course of this study 
but was not confined to those weak calves receiving thymosin. 
'The weights of all calves were recorded at the commence­
ment of thymosin therapy and arc tabulated in Table 15. The 
initial average weight of the normal calves was 546 lbs 
compared to 350 lbs for the we ale calves. After three months 
of thymosin therapy the calves were reweighed. The average 
weight of the normal calves had increased to 682 lbs and the 
average weight of the weak calves had increased to 500 lbs. 
The percent weight increase of the weak calves during the 
three months was found to be significantly greater than that 
of the normal calves (p< 0.001), but the overall weight 
increase was not. Comparisons of the thymosin treated and 
control weak calves as well as thymosin treated and control 
normal calves showed no difference in the percent weight 
gained or the net weight gained. 
Ee-evs,luation of delayed tuberculin hypersensitivity 
of thymosin treated and control animals "was conducted after 
each month of thymosin therapy. The results are given in 
Table 16. In those calves receiving the thymus extract, 
no significant difference was observed in the ability of 
normal and weak calves to respond to the skin test antigen. 
In two of the three re-evaluations conducted in control 
animals, normal calves e:diibited a significantly greater 
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Table 15 A comparison of tlie weights of normal and weak 
calves before and after thymosin therapy. 
Number J'ov'-x--,r<~ A Y/eight Y/t. Incre clSG 
Normal calves - thymosin treated 
12 510 
26 400 
28 640 
average1* 573 
625 
455 
775 
700 
115 
55 
135 
125 
22.5 
13.7 
21.5 
21.7 
Normal calves - controls 
16 520 
1Q 40-3 
21 535 
average 517 
700 
635 
66 
130 
140 
120 
147 
34.6 
O O J 
22.4 
23.4 
345 
368 
Y/eal-: Calves - thymosin treated 
450 570 
270 390 
335 490 
305 455 
455 640 
420 550 
495 
10 
11 
13 
14 
15 
25 
27 
avert 513 
120 
120 
155 
150 
A O <~ 1 09 
130 
150 
145 
26.7 
44.4 
46.3 
49.2 
40.6 
43.5 
42.4 
39.4 
•Veal: calves - controls 
17 305 
18 
20 
22  
O *"» *0 
24 
average 
315 
335 
315 
350 
330 
425 
490 
500 
515 
520 
488 
120 
175 
145 
185 
165 
140 
155 
39.3 
55.5 
43.3 
58.7 
47.1 
36.8 
46.5 
* V;eight -;'-1 represents the weight of the calves o,s of 
7/27/77. The day on which thymosin treatment began. 
** weight v'2 represents the weight of the calves as of 
10/24/77. All thymosin treated calves had received 
three monthly treatments with thymosin by this date. 
t The average of the normal calves treated v.dtii thymosin 
does not include data from calf ;i'26. Calf 25 became ill 
shortly before thymosin treatment and lost consider,able 
weight but was carried through the experiment with the 
other calves. 
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Table 16 Delayed tuberculin responses in normal and weak 
calves during thymosin t!iera.py. 
-V. .v. 
Nuraber Test A'"' Test B'"""r Test C<x"'f" 
Control calves 
Normal 
1 6  
19 
21 
c alve s 
2.0 
1 .25 
0.75 
2.0 
1.25 
0.75 
P.O 
0.5 
1.0 
2 .0  
0.5 
1.0 
1.5 
1.0 
1.5 
1.0 
1.5 x 1.5 
',7 oak calver. 
17 0.75 x 0.75 0.5 x 0.5 N.n. 
13 0.5 x 0.5 0.25 X 0.25 N.R. 
20 0.25 x 0.25 1 .0 x 1 .0 0.25 x 0.25 
22 1 .5 x 1.0 1.5 1'Z 1.25 0.75 x 0.75 
23 0.25 x 0.25 1.0 X 1.0 N.E. 
24 0.5 X 0.5 0.25 X 0.25 0.25 x 0.25 
thymosin treated calves 
ITo r mal c alv e s 
12 0.75 x 0.75 1 .0 x 1 .0 1 .0 1.0 
26 1.0 x 1.0 0.5 x 0.5 1.0 x 0.5 
23 1.5 x 1.5 2.0 x 2.0 1.5 x 2.0 
eak calves 
10 1.25 x 1.25 1 .0 : £ 1.0 0.5 x 0.5 
11 0.5 x 0.5 N.I 0.5 x 0.5 
13 1.5 ; : 1.5 1 . 5 •i'l.O 0.75 x 0.75 
14 0.75 x 0.75 1 .25 -i 0.25 IT .E. 
15 1.3 x 1.5 0 .5 : •: 0.5 1 .0 x 1.0 
O n; 1.25 x 1.25 1 ,2' j  :  :: 1.25 0.75 x 0.75 
27 1.5 x 1.5 1 .0 : :: 1.0 1.5 x 1.0 
Test A - 8/20/77 skin tost 
** Test 13 - 9/23/77 skin test 
*** Test C - 10/24/77 skin tost 
IT.II. = no reaction 
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capacity to respond to the skin test antigen (p < 0,05). 
The significance of the difference in the normal and weak 
calf controls to respond to the skin test antigen was not 
found to be as great .as that observed in the initial delayed 
tuberculin hypersensitivity tests (p< 0.001). It should be 
noted that large fluctuations were observed in the delayed 
hypersensitivity responses of individual animals (both 
normal and weak calves) from test to test. 
An in vitro macrophage migration inhibition assay was 
performed to evaluate the in vitro sensitivity of normal and 
weak calf lymphocytes to the BCG skin test antigen. The 
inhibition of guinea pig macrophages was assayed by indirect 
I.1IF tests using supomates from bovine lymphocyte cultures 
incubated with and without the skin test antigen. All super-
nates tested displayed positive inhibition of macrophage 
migration (Table 17). A 0.80 migration index (20^ inhibition) 
is normally interpreted as a positive response (21). No 
differences were noted -when comparing the average migration 
indices of normal calf controls (0.70) to cither weak coif 
controls (0.67) or to normal calves that had received the 
thymus extract (0.67) or when comparing weak calf controls 
(0.67) to weak calves that huad received the thymus extract 
(0.65). The migration indices of normal and weak calves did 
not show any significant differences when compared as did the 
initial skin tests. 
Table 17 Inhibition of macrophage migration by HIP produced 
by lymphocytes from normal and weak calves 
sensitized with BCG. 
Number I Migration Inde:c"'T y> Inhibition 
Control calves 
Normal calves 
16 0.60 31 
19 0.59 41 
21 0.74 26 
average 0.67 33 
Weak calves 
17 0.72 23 
1 O 
20 0.74 26 
22 0.62 38 
2 jj , 
24 0.61 39 
average 0.67 33 
thymosin tree-ted calves 
Normal calves 
12 0.70 30 
26 0.65 35 
23 0.72 28 
average 0.70 30 
V.'eak calves 
10 0.43 52 
11 0.64 36 
13 1.62 33 
14 0.76 24 
15 0.57 43 
25 0.66 34 
27 0.79 21 
average 0.65 35 
I'!ir:rati on Index area of mlgration with antigen 
area of migration without antigen 
Contamination of these chambers prevented the calculation 
of the ','j macrophage migration inhibition for these samples 
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The Effect of Thymo si no n E-rosotte Formation 
The in vivo and in vitro effects of thymosin on 
E-rosette formation of peripheral blood lymphocytes of 
normal and 'weak calves were examined. PBL separated from 
blood samples of thymosin treated and control animals were 
assayed for E-rosette formation ih the absence a.nd in the 
presence of thymosin (100 jig/ml) • These results are tabulated 
in Table 18. 
No increase in the percentage of the RFC population 
present in P31 v:as observed in normal and weak calves that 
had received thymosin therapy when compared to control calf 
values or their ov/n pre-thymosin values. In vitro incubation 
of PBL with thymosin also resulted in no significant increase 
in the percentage of RFC. 
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Table 13 E-rosette formation of peripheral blood lymphocytes 
of normal and weak calves after in vivo thymosin 
therapy and in vitro incubation with' 'thymosin. 
Number pr e—thymo sin post-thymosin in vitro thymosin 
Control calves 
Normal calves 
16 
15 
21  
average 
13.5 
12.0 
17.0 
14.8 
13.0 
18.0 
14.5 
1 5 . 8  
19.0 
16.5 
15.0 
16.3 
/oak calve 
17 
18 
20 
2 2  
23 
24 
average 
14.5 
18.0 
14.0 
16. o 
14.5 
16.0 
15.7 
15.0 
14.0 
16.5 
13.0 
14.0 
17.5 
15.0 
15.5 
15.5 
17.0 
13.5 
16.0 
19.5 
17.1 
Thymosin treated calves 
Normal calves 
12  
26  
28 
average 
".Veak calve; 
10 
11 
13 
14 
15 
25 
27 
average 
15.0 
13.5 
16.5 
15 .0  
12.5 
13.5 
13.0 
16 .0  
18.0 
13.0 
13 .0  
14.9 
17.0 
14.5 
14.0 
15.2 
18.0 
12.5 
19.0 
17.5 
1 3.0 
15.5 
15.0 
12.0 
13.5 
1 <->. j 
14.5 
14.6 
1 2. 5 
19.0 
16.0 
14.5 
17.5 
20.0 
12.5 
16.5 
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DISCUSSION 
V/'hile a specific etiologic agent of the Weak Calf 
Syndrome has yet to "be ascertained, evidence available sug­
gests that the syndrome is the result of an infectious pro­
cess. After recognition of the syndrome as a possible new 
dises.se entity of neonatal cattle in 19.64, inquiries at 
several ranches in the Bitterroot Valley revealed that 
once the disease was experienced in a herd, the problem 
became enzootic, occurring each year with a varied incidence. 
The disease was particularly evident eraong ranches operating 
an open herd and routinely bringing in replacement heifers. 
Ranches -with a closed herd did not appear to suffer these 
losses. 
An inspection of herd management records from ranches 
with the V;'eak Calf problem revealed that dams appeared to 
abort or give birth to we ale calves only once (61) suggesting 
that the dams develop an immunity to the disea.se. The 
apparent immunity prompted the treatment of afflicted calves 
by transfusions with whole blood obtained from selected dams. 
V/hile this approach appeared to have a beneficial therapeutic 
value, the favorable response was short lived. Since the 
administration latere of cell-free scrum from the same 
.selected dams v:as reported to be much more effective a.s a 
long term benefit, the outcome of a graft—versus-host 
reaction has been suspected in severely afflicted celves 
receiving the complete cellular components. 
A comparative study between animals surviving the 
disease condition and normal calves of comparable ages show 
weak calves to be considerably smaller than their counter­
parts and appear to exhibit varying degrees of a "wasting 
disease." The condition is similar to the runting and 
wasting observed in laboratory mice after neonatal thymectomy 
(313) and other forms of stress (5,54). The calves demon­
strating this "wasting" are characterized by a runted 
appearance, periorbital edema and a rough coat which becomes 
dull, shaggy and matted as the disease progresses. In view 
of the thymic atrophy observed at necropsy in severely 
afflicted calves sue climbing to the disease, the runted 
condition of these calves was assumed to be related to 
the thymus. 
The possibility of immune incompetence occurring ill wealc 
calves is suggested by the depressed lymphocyte proliferation, 
as measured by the standard blastogenic response to PHA 
in vitro, in newborn calves (64) as well as by the inability 
of weak calves to mount delayed hypersensitivity responses 
to tuberculin skin test antigens after appropriate sensiti­
zation (56). The depression in the immune response prompted 
earlier studies with thymosin, a protein thymic extract 
shown capable of restoring immunocompetcnce and reducing 
the incidoncG of wasting in neonatally thymectomiscd mice 
(1,17). The regimen of thymosin therapy used in the treat­
ment of newborn weak calves resulted in an improvement in 
their clinical appearance and general health but was not 
long lasting (64), probably due to the short duration of 
the treatment. 
Because of the problem the V/eak Golf Syndrome repre­
sents to the cattle ranchor, this study was designed to 
evaluate the treatment of weak calves with thymosin over a 
longer period of time in an attempt to correct the "runting" 
associated with the disease. In order to monitor the immune 
status of the weak calf during and after thymosin therapy, 
an assessment of several immune parameters was conducted 
prior to thymosin therapy. 
The assessment of the immune status of the weak calf 
indicates that while weak calves are afflicted with a runting 
syndrome, these animals do not possess gross immunologic 
abnormalities. Except for a depression in delayed tuberculin 
hypersensitivity, no significant differences were noted in 
either the population of circulating lymphocytes or the in 
vitro measurement of cellular immune responsiveness. The 
immunologic depression reported in newborn we ale calves was 
not observed in those weak calves surviving the initial year. 
These calves appear to have overcome the immunosuppressing 
factor(s). During the period of time that separates the 
two groups of '--oak calvcs in age, a return to normal immunologic 
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responsiveness, with the exception of delayed hypersensitivity, 
has occurred. 
Using delayed tuberculin hypersensitivity to monitor 
immune responsiveness in the weak calf, thymosin was 
administered to both normal and weak" calves for a period of 
three months. During this time '/eight gain as veil as 
delayed tuberculin hypersensitivity was monitored in thymosin 
treated and control groups of norms,! and weak calves. 
At the conclusion of thymosin therapy, no disccrnable 
effects of trcatr.iont with the thymic extract were noted in 
the v/eak calves1 general appearance or in their ability to 
attain normal weight. It was noted, however, that the 
general appearance of v/eak calves did improve during this 
time regardless of v/hether they received thymosin or not. 
Also, comparative "/eights of the v/eak calves to normal calves 
increased from 64/' to 74^ suggesting that the initial effects 
of the V;eak Calf Syndrome resulting in the runted appearance 
may be overcome to some degree given sufficient time. 
The effect of thymosin therapy on delayed hypersensi­
tivity in year-old v/eak calves appears inconclusive at this 
point. V/'hile the significant difference that did exist 
between the two groups prior to treatment with, the thymus 
extract disappeared in thymosin treated calves, the decreased 
statistical difference observed in control animals and the 
inconsistencies in responses of individual animals make 
interpretation of the data difficult. Possible explanations 
for these inconsistencies are that the sensitization with 
the BCG vaccine ' as inadequate to achieve a lasting cutaneous 
delayed hypersensitivity or that delayed hypersensitivity 
may not bo an effective method for measuring cellular immune 
responsiveness in cattle. In order to elicit a delayed 
tuberculin response, 309 ug of the skin test antigen is 
required to elicit a response in contrast to the maximum 
5 ug dosage used in man. The ability to mount constant 
and uniform delayed hypersensitivity responses may thus 
not be a suitable testing parameter of the bovine immune 
system. 
The ability of thymosin to increase the number of 
rosette forming cells (RFC) in peripheral blood lymphocytes 
(PBL) obtained from patients with immunological deficiency 
diseases after in vitro incubation with thymosin and after 
in vivo thymosin therapy has been reported in the literature 
(59,60)• These patients include those with primary cell-
mediated immunodeficiencies, thymic hypoplasia, acute systemic 
lupus erythematosus and certain cancer patients. In vitro 
incubation of PBL with thymosin has been shown to be useful 
in identifying irnnunodeficiency patients who may be candi­
dates for in vivo thymosin therapy (50). 
In this study, no increase in the number of HFC .could 
be attributed to thymosin treatment, either in vivo or in 
vitro. The percentage of i!?C in "^BL of normal and weak 
calves before and after thymosin treatment and after in vitro 
incubation • 1th thymosin remained relatively unchanged. 
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The inability of thymocin to affect any changes in the 
percentage of HFC in -"oak calf peripheral blood or the grow 
ancl appearance of year-old -/oak calves indicates that the 
regimen of thymosin therapy used here had no apparent bene­
ficial effect. 
In order to assess fully the therapeutic ability of 
thymosin, additional studies appear warranted. These -studio 
should include a longer period of thymosin therapy and a 
higher concentration of the thymic extract. Because of the 
rapid improvement reported in young calves treated with 
thymosin, it seems probable that the results of thymosin 
therapy are due to an effect other than en increase in 
immunological responsiveness. The possibility of thymosin 
.acting in hormonal regulation must also be investigated. 
The common cmbryological origin of the thymus, thyroid 
and parathyroid glands suggest that the impairment of these 
and other glands may also occur. Thyroidectomised animals 
fail to exhibit normal growth and are characteristically 
smaller than normal animals (11). I'lanif est at ions of hypo­
thyroidism largely depend 011 the age and extent to which the 
deficiency develops. As age progresses, delayed growth and 
development are seen. Ea.rly treatment with thyroid therapy 
in hypothyroid .animals can restore normal growth and 
development. 
The exact mechanism by which thymosin therapy has pro­
duced beneficial results in younger weak calves is unknown, 
r~ O 9 0 
"but interrelationships} "between thymosin and endocrine 
hormones appear likely. If thymosin plays some role in 
hormonal regulation of the growth processes, thymosin 
treatment of older veak calves may "be ineffective since 
the;/- have already attained the majority of their adult 
growth and development. Additional studies should then 
"be concentrated on younger calves and the prevention of 
the associated "runting" rather than trying to correct 
the effects of the disease in older calves. 
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Chapter i> 
ouh;AHY 
An assessment of the irnnunol ogical status of the year-
old weak ealf '"as conducted using in vivo and in vitro 
assays. V.'ith normal calf data serving as ba.seline values, 
no immunologic abnormalities or deficiencies, with the 
exception of a depressed cutaneous delayed tuberculin hyper­
sensitivity, were observed in the v/eak calf. 
An examination of the total and differential leukocyte 
values as well as lymphocyte subpopulatioiis present in 
X-ieripheral blood showed 110 abnormalities in the number of 
circulating lymphocytes to exist in v/eak calves. All data 
fell within the accepted range of normal bovine values (57)• 
Responses indicating normal immunological responsiveness 
were observed in weak calves in studies of in vitro lympho­
cyte proliferation, in vitro lymphocyte production of 
lyrapholcines and in vivo humoral responses to thyinus-dependent 
antigens. 
The in vivo measurement of delayed tuberculin hyper­
sensitivity showed weak calves to have a, depressed ability 
to respond to the BCG skin test antigen. Since lymphocyte 
production of the lymphokiiie I.1P appears to be normal, it 
is possible that this depression in delayed tuberculin hyper­
sensitivity was due to depressed macrophage function or 
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a depression in the ability to mount non-specific inflamraato 
responses. 
Previous studies which describe depression of cellular 
responsiveness in yoking we ale calves, as characterised by 
depressed lymphocyte proliferative responses (64) and the 
inability of • "eak calves to respond to the BCG skin test 
antigen, even after repeated sensitization with the BCG 
vaccine (56), were not observed in this study. These con­
trasting observations majr be due to the age difference 
between the two groups of experimental animals. During the 
time that separates the two groups in age, a return to norma 
immunological responsiveness appears to have taken place. 
Thymosin therapy, which proved beneficial to newborn 
and 1-2 month old calves (64) was also examined in year-old 
calves. The regimen of thymosin therapy used consisted of 
two monthly injections of thymosin, the first (5,000 jag) 
administered in saline and the second (25,000 jig) adminis­
tered in a 50/ saline and 50^ peanut oil emulsion. 
During and after thymosin therapy., a reevaluation of 
delayed tuberculin hypersensitivity was conducted. The 
significantly lower responses initially observed in v/eak 
calves .va,s not seen in \,eak calves receiving thymosin. 
To attribute this change to thymosin would be premature at 
this point because of the inconsistencies observed during 
the repeated- skin testing in both control and experimental 
animals. 
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,-eight gain and general appearance of weak calves was 
also monitored during thymosin therapy and no improvement 
was observed in calves receiving the thymus extract that 
was not observed in control animals. The beneficial 
therapeutic activity observed in nc; born and 1-2 month old 
weak calves may in some way be due to the endocrine in­
volvement of 'thymosin. Because of the age of the calves 
used in this study, these calves may have passed the age 
where correction of endocrine imbalances may be effective 
in "oromotinT normal growth. 
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